COLLEGIUM PHARMACEUTICAL

collegium-pharmaceutical-logo

Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of proprietary, late-stage pharmaceutical products. These products address the growing problems associated with non-medical use and abuse of prescription drugs through formulation based improvements protected by intellectual property (IP). Collegium is focused on building a portfolio of products for the treatment of chronic pain that possess tamper-resistant features and provide extended-release delivery using its patent-protected DETERx formulation platform.

#SimilarOrganizations #People #Financial #Website #More

COLLEGIUM PHARMACEUTICAL

Industry:
Biotechnology Life Science Medical Therapeutics

Founded:
2002-01-01

Address:
Stoughton, Massachusetts, United States

Country:
United States

Website Url:
http://www.collegiumpharma.com

Total Employee:
51+

Status:
Active

Contact:
(781) 713-3699

Email Addresses:
[email protected]

Total Funding:
106 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Sitelinks Search Box Euro IPv6 Yoast WordPress SEO Plugin Google Maps Yoast SEO Premium


Similar Organizations

amivas-logo

Amivas

Amivas is an Australian, Canadian and US joint venture that focuses on the development of therapeutics for the treatment of diseases.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.


Current Advisors List

stephen-j-hoffman_image

Stephen J. Hoffman Board of Directors @ Collegium Pharmaceutical
Board_member
2012-02-01

Current Employees Featured

michael-t-heffernan_image

Michael T. Heffernan
Michael T. Heffernan President , CEO & Chairman of the Board @ Collegium Pharmaceutical
President , CEO & Chairman of the Board

richard-malamut_image

Richard Malamut
Richard Malamut EVP & Chief Medical Officer @ Collegium Pharmaceutical
EVP & Chief Medical Officer
2019-04-01

jane-hirsch_image

Jane Hirsch
Jane Hirsch Co-Founder @ Collegium Pharmaceutical
Co-Founder

not_available_image

Heow Tan
Heow Tan Vice President of Technical Operations @ Collegium Pharmaceutical
Vice President of Technical Operations

scott-dreyer_image

Scott Dreyer
Scott Dreyer EVP & Chief Commercial Officer @ Collegium Pharmaceutical
EVP & Chief Commercial Officer
2018-01-01

not_available_image

Mark Hirsch
Mark Hirsch Founder @ Collegium Pharmaceutical
Founder

joseph-ciaffoni_image

Joseph Ciaffoni
Joseph Ciaffoni President and Chief Executive Officer @ Collegium Pharmaceutical
President and Chief Executive Officer

alison-fleming_image

Alison Fleming
Alison Fleming EVP ,Product Development & Chief Technology Officer @ Collegium Pharmaceutical
EVP ,Product Development & Chief Technology Officer
2017-01-01

john-van-duzer_image

John van Duzer
John van Duzer Vice President of Pharmaceutical Development and Manufacturing @ Collegium Pharmaceutical
Vice President of Pharmaceutical Development and Manufacturing
2020-05-01

Founder


jane-hirsch_image

Jane Hirsch

not_available_image

Mark Hirsch

michael-t-heffernan_image

Michael T. Heffernan

Stock Details


Company's stock symbol is NASDAQ:COLL

Acquisitions List

Date Company Article Price
2022-02-14 BioDelivery Sciences BioDelivery Sciences acquired by Collegium Pharmaceutical 604 M USD

Investors List

eventide-asset-management_image

Eventide

Eventide investment in Private Equity Round - Collegium Pharmaceutical

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Private Equity Round - Collegium Pharmaceutical

adage-capital-management_image

Adage Capital Management

Adage Capital Management investment in Private Equity Round - Collegium Pharmaceutical

tpg-biotech_image

TPG Biotech

TPG Biotech investment in Private Equity Round - Collegium Pharmaceutical

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Private Equity Round - Collegium Pharmaceutical

boston-millennia-partners_image

Boston Millennia Partners

Boston Millennia Partners investment in Private Equity Round - Collegium Pharmaceutical

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Private Equity Round - Collegium Pharmaceutical

longitude-capital_image

Longitude Capital

Longitude Capital investment in Private Equity Round - Collegium Pharmaceutical

skyline-ventures_image

Skyline Ventures

Skyline Ventures investment in Private Equity Round - Collegium Pharmaceutical

aperture-venture-partners_image

Aperture Venture Partners

Aperture Venture Partners investment in Private Equity Round - Collegium Pharmaceutical

Official Site Inspections

http://www.collegiumpharma.com Semrush global rank: 184.57 K Semrush visits lastest month: 428.52 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Collegium Pharmaceutical"

About Collegium Pharmaceutical

Our values Realizing our values. Collegiumโ€™s Core Values are our foundational beliefs that are shared by each member of our team. We are passionate about applying them to all facets of โ€ฆSee details»

Collegium Pharmaceutical - Crunchbase Company โ€ฆ

Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of proprietary, late-stage pharmaceutical products. These โ€ฆSee details»

Collegium Pharmaceutical's Approach

Our portfolio Building a leading, diversified biopharmaceutical company. Collegium is focused on delivering approved medicines with potential to improve the lives of people living with serious medical conditions, including severe and persistent โ€ฆSee details»

Collegium Appoints Vikram Karnani as Chief Executive Officer

Nov 7, 2024 Vikram Karnani is a Proven Industry Leader with Extensive Experience Growing Commercial Biopharmaceutical Businesses. STOUGHTON, Mass., Nov. 07, 2024 (GLOBE โ€ฆSee details»

Collegium Pharmaceutical โ€“ Medical Affairs

For all product or services-related questions, please email: [email protected] or call: (855) 331-5615. Product complaint or adverse event? Contact Collegium Medical โ€ฆSee details»

Working at Collegium Pharmaceutical - Zippia

Mar 14, 2024 www.collegiumpharma.com. Organization Type. Public. CEO. Joseph J. Ciaffoni. Collegium Pharmaceutical is a specialty pharmaceutical company focusing on the โ€ฆSee details»

Collegium Pharmaceutical Inc - Company Profile - GlobalData

Website www.collegiumpharma.com Telephone 1 781 7133699. No of Employees 357. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange COLL (NASD) Revenue (2024) โ€ฆSee details»

Collegium Pharma Org Chart + Executive Team - The Official Board

Www.collegiumpharma.com. has 18 executives +1 781 713 3699; Add an executive. Collegium Pharma (COLL) News . Anything missing? We search for you. Print or download . CEO & โ€ฆSee details»

Collegium Pharmaceutical, Inc. - Dun & Bradstreet

Company Description: Collegium Pharmaceutical is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. โ€ฆSee details»

Collegium Pharmaceutical, Inc. Company Information - Drugs.com

Sep 11, 2015 Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided โ€ฆSee details»

Collegium Pharmaceutical (COLL) Company Profile & Description

May 7, 2015 Company profile for Collegium Pharmaceutical, Inc. (COLL) stock, with a description, list of executives, contact details and other key facts.See details»

Collegium Pharmaceutical - Overview, News & Similar ... - ZoomInfo

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024 STOUGHTON, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: โ€ฆSee details»

Collegium Pharmaceutical

Apr 1, 2025 Collegium Pharmaceutical is a biopharmaceutical company committed to improving the lives of people living with serious medical conditions.See details»

Investors Overview โ€“ Collegium Pharmaceutical Inc.

Corporate Profile. Collegium Pharmaceutical is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions.See details»

Careers at Collegium Pharmaceutical - Ironshore

We aim to foster a stronger, smarter and more informed organization every day. grow with us. We encourage employees at all levels to act as leaders. Our set of Leadership Behaviors are โ€ฆSee details»

Collegium Announces Updates to its Board of Directors and โ€ฆ

Mar 17, 2025 Dean J. Patras most recently served as Vice President, Human Resources for Amgenโ€™s Rare Disease Business Unit, where he played a pivotal role in the integration of โ€ฆSee details»

Collegium Pharmaceutical: Employee Directory | ZoomInfo.com

Collegium Pharmaceutical Contact Info: Website: www.collegiumpharma.com What does Collegium Pharmaceutical do? Collegium Pharmaceutical, Inc., a specialty pharmaceutical โ€ฆSee details»

Collegium Provides 2025 Financial Guidance and Business Update

Jan 8, 2025 โ€“ Product Revenues, Net Expected in the Range of $735 Million to $750 Million โ€“ โ€“ Jornay PM ® Net Revenue Expected to be in Excess of $135 Million โ€“ โ€“ Adjusted EBITDA* โ€ฆSee details»

Collegium Appoints Vikram Karnani as Chief Executive Officer

Nov 7, 2024 Vikram Karnani is a Proven Industry Leader with Extensive Experience Growing Commercial Biopharmaceutical BusinessesSTOUGHTON, Mass., Nov. 07, 2024 (GLOBE โ€ฆSee details»

Collegium Pharmaceutical, Inc. - Cruelty Free Investing

Collegium Pharmaceutical, Inc. is a clinical-stage pharmaceutical company, which focuses on the development of proprietary, late stage pharmaceutical products. These products target market โ€ฆSee details»

linkstock.net © 2022. All rights reserved